Penicillin g benzathine - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for penicillin g benzathine and what is the scope of freedom to operate?
Penicillin g benzathine
is the generic ingredient in five branded drugs marketed by King Pharms Llc, Wyeth Ayerst, and Casper Pharma Llc, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for penicillin g benzathine. Two suppliers are listed for this compound.
Summary for penicillin g benzathine
| US Patents: | 0 |
| Tradenames: | 5 |
| Applicants: | 3 |
| NDAs: | 6 |
| Drug Master File Entries: | 5 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Clinical Trials: | 25 |
| What excipients (inactive ingredients) are in penicillin g benzathine? | penicillin g benzathine excipients list |
| DailyMed Link: | penicillin g benzathine at DailyMed |
Recent Clinical Trials for penicillin g benzathine
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of California, Los Angeles | PHASE2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | PHASE2 |
| Nanfang Hospital, Southern Medical University | PHASE4 |
Pharmacology for penicillin g benzathine
| Drug Class | Penicillin-class Antibacterial |
Medical Subject Heading (MeSH) Categories for penicillin g benzathine
US Patents and Regulatory Information for penicillin g benzathine
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| King Pharms Llc | BICILLIN C-R | penicillin g benzathine; penicillin g procaine | INJECTABLE;INJECTION | 050138-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| King Pharms Llc | BICILLIN L-A | penicillin g benzathine | INJECTABLE;INJECTION | 050141-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| King Pharms Llc | BICILLIN C-R 900/300 | penicillin g benzathine; penicillin g procaine | INJECTABLE;INJECTION | 050138-003 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch